Trial
NCT00401947
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of ACH-0137171 in Participants With Chronic Hepatitis C Infection
Phase IITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
Alexion Pharmaceuticals, Inc.
Collaborators
Achillion, a wholly owned subsidiary of Alexion
Condition
HCV Infection
Intervention
ACH-0137171
Why stopped
Nephrotoxicity
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-09-15